Cell-based bone reconstruction therapies - Principles of clinical approaches

International Journal of Oral and Maxillofacial Implants

Volumn 21, Issue 6, 2006, Pages 899-906

  Meyer, Ulrich ^a   Wiesmann, Hans Peter ^b   Berr, Karin ^a   Kübler, Norbert R ^a   Handschel, Jörg ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Bone reconstruction; Bone tissue engineering; Clinical treatment; Stem cells

Indexed keywords

ANIMAL; ARTICLE; BONE; BONE TRANSPLANTATION; CULTURE TECHNIQUE; CYTOLOGY; GENETIC ENGINEERING; HUMAN; METHODOLOGY; PLASTIC SURGERY; TISSUE ENGINEERING;

ANIMALS; BONE AND BONES; BONE TRANSPLANTATION; CELL CULTURE TECHNIQUES; GENETIC ENGINEERING; HUMANS; RECONSTRUCTIVE SURGICAL PROCEDURES; TISSUE ENGINEERING;

EID: 33846275891     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (108)

1. Cricchio G, Lundgren S. Donor site morbidity in two different approaches to anterior iliac crest bone harvesting. Clin Implant Dent Relat Res 2003;5:161-169.
2. Frohberg U, Mazock JB. A review of morbidity associated with bone harvest from the proximal tibial metaphysis. Mund Kiefer Gesichtschir 2005;9:63-65.
3. Kessler P, Thorwarth M, Bloch-Birkholz A, Nkenke E, Neukam FW. Harvesting of bone from the iliac crest-Comparison of the anterior and posterior sites. Br J Oral Maxillofac Surg 2005;43:51-56.
4. Nkenke E, Weisbach V, Winckler E, Schulze-Mosgau S, Wiltfang J, Neukam FW. Morbidity of harvesting of bone grafts from the iliac crest for preprosthetic augmentation procedures: A prospective study. Int J Oral Maxillofac Surg 2004;33:157-163.
5. Mistry AS, Mikos AG. Tissue engineering strategies for bone regeneration. Adv Biochem Eng Biotechnol 2005;94:1-22.
6. Mooney DJ, Boontheekul T, Chen R, Leach K. Actively regulating bioengineered tissue and organ formation. Orthod Craniofac Res 2005;8:141-144.
7. Tuan RS, Boland G, Tuli R. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 2003;5:32-45.
8. Vacanti CA, Vacanti JP. Bone and cartilage reconstruction with tissue engineering approaches. Otolaryngol Clin North Am 1994;27:263-276.
9. Handschel J, Wiesmann HP, Stratmann U, Kleinheinz J, Meyer U, Joos U. TCP is hardly resorbed and not osteoconductive in a non-loading calvarial model. Biomaterials 2002;23:1689-1695.
10. Cohen SR, Holmes RE, Meltzer HS, Levy ML, Beckett MZ. Craniofacial reconstruction with a fast resorbing polymer: A 6- to 12-month clinical follow-up review. Neurosurg Focus 2004;16:E12.
11. Holmes RE, Cohen SR, Cornwall GB, Thomas KA, Kleinhenz KK, Beckett MZ. MacroPore resorbable devices in craniofacial surgery. Clin Plast Surg 2004;31:393-406.
12. Thaller SR, Hoyt J, Borjeson K, Dart A, Tesluk H. Reconstruction of calvarial defects with anorganic bovine bone mineral (Bio-Oss) in a rabbit model. J Craniofac Surg 1993;4:79-84.
13. Velich N, Nemeth Z, Hrabak K, Suba Z, Szabo G. Repair of bony defect with combination biomaterials. J Craniofac Surg 2004;15:11-15.
14. Kubler NR, Wurzler KK, Reuther JF, Sieber E, Kirchner T, Sebald W. Effect of different factors on the bone forming properties of recombinant BMPs. Mund Kiefer Gesichtschir 2000;4(suppl 2):S465-S469.
15. Terheyden H, Knak C, Jepsen S, Palmie S, Rueger DR. Mandibular reconstruction with a prefabricated vascularized bone graft using recombinant human osteogenic protein-1: An experimental study in miniature pigs. Part I: Prefabrication. Int J Oral Maxillofac Surg 2001;30:373-379.
16. Lang NP, Hammerle CH, Bragger U, Lehmann B, Nyman SR. Guided tissue regeneration in jawbone defects prior to implant placement. Clin Oral Implants Res 1994;5:92-97.
17. Hämmerle CH, Chiantella GC, Karring T, Lang NP. The effect of a deproteinized bovine bone mineral on bone regeneration around titanium dental implants. Clin Oral Implants Res 1998;9:151-162.
18. Meyer U, Kleinheinz J, Joos U. Biomechanical and clinical implications of distraction osteogenesis in craniofacial surgery. J Craniomaxillofac Surg 2004;32:140-149.
19. Schliephake H. Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 2002;31:469-484.
20. Meyer U, Kruse-Lösler B, Wiesmann HP. Principles of bone formation driven by biophysical forces in craniofacial surgery. Br J Oral Maxillofac Surg 2006;44:289-295.
21. Zins J E, Whitaker LA. Membranous versus endochondral bone: Implications for craniofacial reconstruction. Plast Reconstr Surg 1983;72:778-785.
22. Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997;64:278-294.
23. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 1997;64:295-312.
24. Joyner CJ, Bennett A, Triffitt JT. Identification and enrichment of human osteoprogenitor cells by using differentiation stage-specific monoclonal antibodies. Bone 1997;21:1-6.
25. Meyer U, Meyer T, Jones DB. Attachment kinetics, proliferation rates and vinculin assembly of bovine osteoblasts cultured on different pre-coated artificial substrates. J Mater Sci Mater Med 1998;9:301-307.
26. Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 2001;19:180-192.
27. Ohgushi H, Caplan Al. Stem cell technology and bioceramics: From cell to gene engineering. J Biomed Mater Res 1999;48:913-927.
28. Grundet RE, Chapman CW, Yee T, Moore DC. Autogeneic bone marrow and porous biphasic calcium phosphate ceramic for segmental bone defects in the canine ulna. Clin Orthop Relat Res 1991;266:244-258.
29. Wolff D, Goldberg VM, Stevenson S. Histomorphometric analysis of the repair of a segmental diaphyseal defect with ceramic and titanium fibermetal implants: Effects of bone marrow. J Orthop Res 1994;12:439-446.
30. Perka C, Schultz O, Spitzer RS, Lindenhayn K, Burmester GR, Sittinger M. Segmental bone repair by tissue-engineered periosteal cell transplants with bioresorbable fleece and fibrin scaffolds in rabbits. Biomaterials 2000;21:1145-1153.
31. Caplan Al. Review: mesenchymal stem cells: Cell based reconstructive surgery in orthopedics. Tissue Eng 2005;11:1198-1211.
32. Jackson IT, Scheker LR, Vandervord JG, McLennan JG. Bone marrow grafting in the secondary closure of alveolar-palatal defects in children. Br J Plast Surg 1981;34:422-425.
33. Ohgushi H, Goldberg VM, Caplan Al. Heterotopic osteogenesis in porous ceramics induced by marrow cells. J Orthop Res 1989;7:568-578.
34. Nakahara H, Bruder SR Goldberg VM, Caplan Al. In vivo osteochondrogenic potential of cultured cells derived from the periosteum. Clin Orthop Relat Res 1990;259:223-232.
35. Bruder SP, Kurth AA, Shea M, Hayes WC, Jaiswal N, Kadiyala S. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 1998;16:155-162.
36. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
37. Simmons PJ, Torok-Storb B. Identification of stromal cell pre-cursors in human bone marrow by a novel monoclonal anti-body, STRO-1. Blood 1991;78:55-62.
38. Stewart K, Walsh S, Screen J, et al. Further characterization of cells expressing STRO-1 in cultures of adult human bone marrow stromal cells. J Bone Miner Res 1999;14:1345-1356.
39. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001;98:2615-2625.
40. Aubin JE. Bone stem cells. J Cell Biochem 1998;30(suppl):73-82.
41. Aubin JE. Advances in the osteoblast lineage. Biochem Cell Biol 1998;76:899-910.
42. Egrise D, Martin D, Vienne A, Neve P, Schoutens A. The number of fibroblastic colonies formed from bone marrow is decreased and the in vitro proliferation rate of trabecular bone cells increased in aged rats. Bone 1992;13:355-361.
43. Quarto R, Thomas D, Liang CT. Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif Tissue Int 1995;56:123-129.
44. Haynesworth SE, Goshima J, Goldberg VM, Caplan Al. Characterization of cells with osteogenic potential from human marrow. Bone 1992;13:81-88.
45. Wong M, Tuan RS. Nuserum, a synthetic serum replacement, supports chondrogenesis of embryonic chick limb bud mesenchymal cells in micromass culture. In Vitro Cell Dev Biol Anim 1993;29A:917-922.
46. Goldsborough MD, Tilkins ML, Price PJ, Lobo-Alfonso J, Morrison JR, Stevens ME. Serum-free culture of murine embryonic stem (ES) cells. Focus 1998;20:8-12.
47. Kübier NR, Wurzler KK, Reuther JF, Sieber E, Kirchner T, Sebald W. Effect of different factors on bone forming properties of recombinant BMPs. Mund Kiefer Gesichtsch 2000;4:465-469.
48. Hutmacher DW, Sittinger M. Periosteal cells in bone tissue engineering. Tissue Eng 2003;9(suppl 1):S45-S64.
49. Vacanti CA, Kim W, Upton J, Mooney D, Vacanti JP. The efficacy of periosteal cells compared to chondrocytes in the tissue engineered repair of bone defects. Tissue Eng 1995;1:301-308.
50. Friedenstein AJ. Precursor cells of mechanocytes. Int Rev Cytol 1976;47:327-359.
51. Nuttall ME, Patton AJ, Olivera DL, Nadeau DP, Gowen M. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: Implications for osteopenic disorders. J Bone Miner Res 1998;13:371-382.
52. Triffitt JT, Oreffo ROC. Osteoblast lineage. In: Zaidi M (ed). Molecular and Cellular Biology of Bone. Advances in Organ Biology Series. Greenwich, CT: JAI Press, 1998;5B:429-451.
53. Kanou M, Ueno T, Kagawa T, et al. Osteogenic potential of primed periosteum graft in the rat calvarial model. Ann Plast Surg 2005;54:71-78.
54. Spitzer RS, Perka C, Lindenhayn C, Zippel H. Matrix engineering for osteogenic differentiation of rabbit periosteal cells using alpha-tricalcium particles in a three dimensional fibrin culture. J Biomed Mater Res 2002;59:690-696.
55. Nakahara H, Goldberg VM, Caplan AI. Culture-expanded periosteal-derived cells exhibit osteochondrogenic potential in porous calcium phosphate ceramics in vivo. Clin Orthop Relat Res 1992;276:291-298.
56. Wiesmann H P, Nazer N, Klatt C, Szuwart T, Meyer U. Bone tissue engineering by primary osteoblast-like cells in a monolayer system and 3-dimensional collagen gel. J Oral Maxillofac Surg 2003;61:1455-1462.
57. Bahrami S, Stratmann U, Wiesmann HP, Mokrys K, Bruckner P, Szuwart T. Periosteally derived osteoblast-like cells differentiate into chondrocytes in suspension culture in agarose. Anat Rec 2000;259:124-130.
58. Schantz JT, Hutmacher DW, Chim H, Ng KW, Lim TC, Jeoh SH. Induction of ectopic bone formation by using human periosteal cells in combination with a novel scaffold technology. Cell Transplant 2002;11:125-138.
59. Schantz JT, Hutmacher DW, Ng KW, Khor HL, Lim MT, Jeoh SH. Evaluation of a tissue-engineered membrane-cell construct for guided bone regeneration. Int J Oral Maxillofac Implants 2002;17:161-174.
60. Ashton BA, Allen TD, Howlett CR, Eaglesom CC, Hattori E, Owen M. Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clin Orthop Relat Res 1980;151:294-307.
61. Ohgushi H, Goldberg VM, Caplan Al. Heterotopic osteogenesis in porous ceramics induced by marrow cells. J Orthop Res 1998;7:568-578.
62. Girdler NM, Hosseini M. Orbital floor reconstruction with autogenous bone harvested from the mandibular lingual cortex. Br J Oral Maxillofac Surg 1992;30:36-38.
63. Chen NT, Glowacki J, Bucky LP, Hong HZ, Kim WK, Yaremchuk MJ. The roles of revascularization and resorption on endurance of craniofacial onlay bone grafts in the rabbit. Plast Reconstr Surg 1994;93:714-722.
64. Schwipper V, von Wild K, Tilkorn H. Reconstruction of frontal bone, periorbital and calvarial defects with autogenic bone. Mund Kiefer Gesichtschir 1997;1(suppl 1):S71-S74.
65. Marx RE, Miller RI, Ehler WJ, Hubbard G, Malinin TI. A comparison of particulate allogeneic and paniculate autogenous bone grafts into maxillary alveolar clefts in dogs. J Oral Maxillofac Surg 1984;42:3-9.
66. Shirota T, Ohno K, Motohashi M, Michi K. Histologic and microradiologic comparison of block and particulate cancellous bone and marrow grafts in reconstructed mandibles being considered for dental implant placement. J Oral Maxillofac Surg 1996;54:15-20.
67. Springer IN, Jerheyden H, Geiss S, Harle F, Hedderich J, Acil Y. Participated bone grafts-Effectiveness of bone cell supply. Clin Oral Implants Res 2004;15:205-212.
68. Ecarot-Charrier B, Glorieux FH, van der Rest M, Pereira G. Osteoblasts isolated from mouse cal varia initiate matrix mineralization in culture. J Cell Biol 1983;96:639-643.
69. Talmagde JE. The combination of stem cell transplantation and immunotherapy: Future potential. In Vivo 1994;8:675-690.
70. Verna IM, Somia N. Gene therapy-Promises, problems and prospects. Nature 1997;389:239-242.
71. Sato GH. Animal cell culture. In: Lanza R, Langer R, Chick W (eds). Principles of Tissue Engineering. Austin, TX: R.G. Landes, 1997;101-109.
72. Meiser BM, Reichart B. New trends in clinical immunosuppression. Transplant Proc 1994;26:3181-3183.
73. Sefton MV, May MH, Lahooti S, Babensee JE. Making microencapsulation work: Conformal coating, immobilization gels and in vivo performance. J Control Release 2000;65:173-186.
74. Evans CH, Robbins PD. Possible orthopaedic applications of gene therapy. J Bone Joint Surg Am 1995;77:1103-1114.
75. Robbins PD, Ghivizzani SC. Viral vectors for gene therapy. Pharmacol Ther 1998;80:35-47.
76. Hannallah D, Peterson B, Lieberman JR, Fu FH, Huard J. Gene therapy in orthopaedic surgery. J Bone Joint Surg Am 2002;84:1046-1061.
77. Baltzer AW, Lieberman JR. Regional gene therapy to enhance bone repair. Gene Ther 2004;11:344-350.
78. Partridge KA, Oreffo RO. Gene delivery in bone tissue engineering: Progress and prospects using viral and nonviral strategies. Tissue Eng 2004;10:295-307.
79. Evans CH, Robbins PD. Possible orthopaedic applications of gene therapy. J Bone Joint Surg Am 1995;77:1103-1114.
80. Robbins PD. Ghivizzani SC. Viral vectors for gene therapy. Pharmacol Ther 1998:80:35-47.
81. Alden TD, Pittman DD, Hankins GR, et al. In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector. Hum Gene Ther 1999;10:2245-2253.
82. Musgrave DS, Bosch P, Ghivizzani S, Robbins PD, Evans CH, Huard J. Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone 1999;24:541-547.
83. Baltzer AW, Lattermann C, Whalen JD, et al. Genetic enhancement of fracture repair: Healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther 2000;7:734-739.
84. Okubo Y, Bessho K, Fujimura K, Iizuka T, Miyatake SI. Osteoinduction by bone morphogenetic protein-2 via adenoviral vector under transient immunosuppression. Biochem Biophys Res Commun 2000;267:382-387.
85. Blum JS, Parrott MB, Mikos AG, Barry MA. Early osteoblastic differentiation induced by dexamethasone enhances adenoviral gene delivery to marrow stromal cells. J Orthop Res 2004:411-416.
86. Beresford JN. Osteogenic stem cells and the stromal system of bone and marrow. Clin Orthop Relat Res 1989;240:270-280.
87. Fang J, Zhu YY, Smiley E, et al. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci USA 1996;93:5753-5758.
88. Bonadio J, Smiley E, Patil P, Goldstein S. Localized, direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration. Nat Med 1999;5:753-759.
89. Rice MA, Dodson BT, Arthur JA, Anseth KS. Cell-based therapies and tissue engineering. Otolaryngol Clin North Am 2005;38:199-214.
90. Fuerst G, Tangl S, Gruber R, Gahleitner A, Sanroman F, Watzek G. Bone formation following sinus grafting with autogenous bone-derived cells and bone mineral in minipigs: Preliminary findings. Clin Oral Implants Res 2004;15:733-740.
91. Meyer U, Joos U, Wiesmann HP. Biological and biophysical principles in extra corporeal bone tissue engineering. Int J Oral Maxillofac Surg 2004;33:635-641.
92. Abukawa H, Shin M, Williams WB, Vacanti JP, Kaban LB, Troulis MJ. Reconstruction of mandibular defects with autologous tissue-engineered bone. J Oral Maxillofac Surg 2004;62:601-606.
93. Schimming R, Schmelzeisen R. Tissue-engineered bone for maxillofacial sinus augmentation. J Oral Maxillofac Surg 2004;62:724-729.
94. Zadeh HH. Implant site development: Clinical realities of today and the prospects of tissue engineering. J Calif Dent Assoc 2004;32:1011-1020.
95. Meyer U, Büchter A, Wiesmann HP, Joos U, Jones DB. Basic reactions of osteoblasts on structured material surfaces. Eur Cell Mater 2005;9:39-49.
96. Dunn CA, Jin Q, Taba M Jr, Franceschi RT, Bruce Rutherford R, Giannobile WV. BMP gene delivery for alveolar bone engineering at dental implant defects. Mol Ther 2005;11:294-299.
97. Zadeh HH, Daftary F. Minimally invasive surgery: An alternative approach for periodontal and implant reconstruction. J Calif Dent Assoc 2004;32:1022-1030.
98. Yamada Y, Ueda M, Naiki T, Nagasaka T. Tissue-engineered injectable bone regeneration for osseointegrated dental implants. Clin Oral Implants Res 2004;15:589-597.
99. Ratner BD. Replacing and renewing: Synthethic materials, biomimetics,and tissue engineering in implant dentistry. J Dent Educ 2001;65:1340-1347.
100. Chen F, Ouyang H, Feng X, et al. Anchoring dental implant in tissue-engineered bone using composite scaffold: A preliminary study in nude mouse model. J Oral Maxillofac Surg 2005;63:586-591.
101. Buser D, Martin W, Belser UC. Optimizing esthetics for implant restorations in the anterior maxilla: Anatomic and surgical considerations. Int J Oral Maxillofac Surg 2004;19:S43-S61.
102. Drury JL, Mooney JR. Hydrogels for tissue engineering: Scaffold design variables and application. Biomaterials 2003;4337-4351.
103. Silva EA, Mooney DJ. Synthetic extracellular matrices for tissue engineering and regeneration. Curr Top Dev Biol 2004;64:181-205.
104. Chen RR, Mooney DJ. Polymeric growth factor delivery strategies for tissue engineering. 2003;1103-1112.
105. Richardson TP, Murphy WL, Mooney DJ. Polymeric delivery of proteins and plasmid DNA for tissue engineering and gene therapy. Crit Rev Eukaryot Gene Expr 2001;47-58.
106. Leach JK, Mooney DJ. Bone engineering by controlled delivery of osteoinductive molecules. Expert Opin Biol Ther 2004;4:1015-1027.
107. Meyer U, Wiesmann HP. Bone and Cartilage Tissue Engineering. Berlin: Springer, 2006.
108. Young CS, Abukawa H, Asrican R, et al. Tissue-engineered hybrid tooth and bone. Tissue Eng 2005;11:1599-1610.